The Southeast Stem Cell Consortium is dedicated to the promotion of induced pluripotent stem cell (iPSC) research throughout the southeastern region of the United States.
The Southeast Stem Cell Consortium performs a critical role in the coordination of iPSC research to promote basic discovery and to translate this into new therapeutics, diagnostics and cures. Founded in 2008, the consortium supports research using iPSC technology relating to tissue repair (spinal cord injury and head trauma), cardiovascular disease and stroke, metabolic diseases including diabetes and obesity, neurodegenerative disorders including Parkinsons disease, Alzheimer’s disease/dementia and, amyotrophic lateral sclerosis (ALS). Discoveries in these areas will serve as a platform to develop next generation drugs, therapeutics and diagnostics. These therapies will have utility in areas for which there are currently no effective treatments or solutions.